Osaic Holdings’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $621 | Buy |
102
+58
| +132% | +$353 | ﹤0.01% | 6792 |
|
|
2025
Q1 | $672 | Buy |
44
+5
| +13% | +$76 | ﹤0.01% | 6764 |
|
|
2024
Q4 | $719 | Sell |
39
-224
| -85% | -$4.13K | ﹤0.01% | 6764 |
|
|
2024
Q3 | $2.93K | Sell |
263
-36
| -12% | -$401 | ﹤0.01% | 6305 |
|
|
2024
Q2 | $2.8K | Sell |
299
-49
| -14% | -$459 | ﹤0.01% | 6320 |
|
|
2024
Q1 | $11.4K | Buy |
348
+117
| +51% | +$3.84K | ﹤0.01% | 5615 |
|
|
2023
Q4 | $6.18K | Sell |
231
-798
| -78% | -$21.3K | ﹤0.01% | 6004 |
|
|
2023
Q3 | $62.2K | Buy |
1,029
+39
| +4% | +$2.36K | ﹤0.01% | 4829 |
|
|
2023
Q2 | $101K | Buy |
990
+8
| +0.8% | +$815 | ﹤0.01% | 4424 |
|
|
2023
Q1 | $174K | Sell |
982
-21
| -2% | -$3.71K | ﹤0.01% | 3982 |
|
|
2022
Q4 | $388K | Buy |
1,003
+853
| +569% | +$330K | ﹤0.01% | 3256 |
|
|
2022
Q3 | $52K | Sell |
150
-6
| -4% | -$2.08K | ﹤0.01% | 4873 |
|
|
2022
Q2 | $51K | Sell |
156
-21
| -12% | -$6.87K | ﹤0.01% | 4947 |
|
|
2022
Q1 | $1.71M | Buy |
177
+6
| +4% | +$58.1K | ﹤0.01% | 2071 |
|
|
2021
Q4 | $74K | Buy |
171
+1
| +0.6% | +$433 | ﹤0.01% | 4832 |
|
|
2021
Q3 | $94K | Buy |
170
+21
| +14% | +$11.6K | ﹤0.01% | 4582 |
|
|
2021
Q2 | $76K | Sell |
149
-56
| -27% | -$28.6K | ﹤0.01% | 4715 |
|
|
2021
Q1 | $160K | Sell |
205
-24
| -10% | -$18.7K | ﹤0.01% | 3946 |
|
|
2020
Q4 | $126K | Sell |
229
-11
| -5% | -$6.05K | ﹤0.01% | 3882 |
|
|
2020
Q3 | $110K | Sell |
240
-125
| -34% | -$57.3K | ﹤0.01% | 3743 |
|
|
2020
Q2 | $225K | Sell |
365
-72
| -16% | -$44.4K | ﹤0.01% | 3030 |
|
|
2020
Q1 | $207K | Buy |
+437
| New | +$207K | ﹤0.01% | 2836 |
|